Investing Profile

Vineeta Agarwala

VCInvestor

General Partner @a16z; Physician @Stanford

a16z.com/author/vineeta-agarw...San Francisco Bay Area

‌

Your Intro Paths to Vineeta Agarwala

‌

Find Vineeta Agarwala on

Current Investing Position

Andreessen Horowitz General Partner

Investment Range

$10K - $100.0M

Sweet Spot

$10.0M

Investments On Record

Current Fund Size

$2.2B

Vineeta Agarwala is on these Sector & Stage Rankings

BioTech (Series B)BioTech (Series A)Health IT (Series A)San Francisco Bay Area Health IT (Series B)

Vineeta Agarwala's Investments On Record (17)

Company	StageDateRound Size	Total Raised
Arda Therapeutics	Series AOct 2024$43M	$43M
Co-investors: Matthew Caspari (Alumni Ventures ), Konstantin von Unger
Thyme Care	Series CJul 2024$55M Series BAug 2023$60M Series AOct 2021$22M	$140M
Co-investors: Kurt Sheline (Echo Health Ventures), Brenton Fargnoli (AlleyCorp), Vijay Patel (CVS Health), David Whelan (Town Hall Ventures), Vivek Garipalli
Pomelo Care	Series BJun 2024$46M Series AJun 2023$33M	$79M
Co-investors: Josh Kopelman (First Round Capital)
Santa Ana Bio	Series BJun 2024$130M	$170M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Christine Borowski (Access Biotechnology), Jerel Davis (Versant Ventures), Peter Emtage (Versant Ventures), Shinichiro Fuse
Valar Labs	Series AMay 2024$22M	$26M
Co-investors: James Hardiman (DCVC (Data Collective)), Cavin Mozarmi (REMUS Capital), Nikita Andersson (Hummingbird Ventures), Steve Blank (M34 Capital), Johannes Schildt
knownwell	Series ADec 2023$20M	$25M
Co-investors: Ian Chiang (Flare Capital Partners), Larry Summers, Varsha Rao
Gate Bioscience	Series ANov 2023$60M	$60M
Co-investors: Scott Biller (GV (Google Ventures)), Jay Parrish (ARCH Venture Partners), Clare Ozawa (Versant Ventures)
Waymark	Series UnknownOct 2023$42M Series AJan 2022$45M	$87M
Co-investors: Mohamad Makhzoumi (New Enterprise Associates (NEA))

Vineeta Agarwala's Media (2)

Bio Eats World: The Genetics of Risk - Andreessen Horowitz

a16z.com

Agarwala abandons GV for Andreessen Horowitz - Corporate Venturing: News, Data, and Events - Global Corporate Venturing

globalcorporateventuring.com

most interested in

therapeutics, diagnostics, and digital health, with a focus on companies that are leveraging unique datasets to improve drug development and patient care delivery

Investors who invest with Vineeta Agarwala